Introduction {#Sec1}
============

Hematoporphyrin (**1**), the first compound that was tried in photodynamic therapy (PDT), contains, besides the basic porphyrin ring, two carboxyethylene groups. Photofrin, currently the most frequently used porphyrin-type compound in anticancer therapy, was obtained from hematoporphyrin (**1**) (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR1]\]. Photofrin molecules contain carboxyl (carboxyethylene) groups which give the compound its hydrophobic and hydrophilic properties. Photofrin preparations are, however, a mixture of several porphyrin compounds. Numerous research teams around the world have been trying to obtain novel compounds with precisely determined structure and controlled biological properties \[[@CR2]--[@CR4]\]. Several of these compounds are derivatives of tetraphenylporphyrin (**2**) (tetraarylporphyrin, Fig. [1](#Fig1){ref-type="fig"}). The aryl fragments in these porphyrins are modified by substituting hydrogen atoms with various groups altering the hydrophobic--hydrophilic character of the whole molecule, most often without changing its photochemical properties.Fig. 1Hematoporphyrin and tetraphenylporphyrin

Simple tetraarylporphyrins are highly soluble in slightly polar solvents, most often halogenated or DMF; these however cannot be used in biological investigations except at the stage of preparing photosensitizer--carrier systems, e.g. liposomes. Most synthetic porphyrins are not very soluble in simple alcohols. Some porphyrins are soluble in water which makes them suitable for basic biological studies. Introduction of strongly polar groups, for example ammonium or sulfone groups, enables dissolution of tetraarylporphyrins in water. Suitably modified porphyrins can be incorporated into lipid membranes, micelles, or liposomes; in this form they are delivered into cells \[[@CR5]--[@CR13]\]. Porphyrin carriers of this type are very promising, because most of the porphyrins obtained synthetically are strongly hydrophobic which makes them useless in investigations of direct PDT or other therapeutic applications. Derivatives with acidic moieties at the ends of alkyl chains have not yet been studied for their applicability in photodynamic therapy. Compounds with alkyl chains of different lengths separating the porphyrin fragment from the carboxyl group were chosen for study. Hydrophobic--hydrophilic character is responsible for a variety of the properties of organic compounds, for example solubility, permeability through semi-permeable membranes (for example cell membranes), and ability to anchor in lipid layers. Most importantly, for PDD and PDT it is responsible for the manner of transport of photosensitizer molecules into the living organism. The easiest way to verify the assumed properties of a compound is by synthesis of the compound.

In search of novel potential photosensitizers we obtained a series of carboxyalkyloxy tetraphenylporphyrin derivatives **4**--**8** (Fig. [2](#Fig2){ref-type="fig"}). Carboxyl groups are attached to one of the phenyl rings of tetraphenylporphyrin via alkyl chains of different lengths. Previously, compounds with *n* = 1 and *n* = 3 were obtained as intermediates during the synthesis of more complex tetraphenylporphyrin derivatives. In particular, cholesterol derivatives of carboxymethylporphyrin (*n* = 1) were synthesized and their gelator properties described \[[@CR14]\]. Butyric acid (*n* = 3) was attached to arylporphyrin via an ether bond in order to obtain a porphyrin with an easily modifiable fragment (in this case a COOH group). Next, it was substituted using either lipophilic guanosine in order to examine the self-assembly of this group \[[@CR15]\] or with a tyrosine group when obtaining modified TiO~2~ clusters in which photoinduced electron transfer occurred \[[@CR16]\]. Amide derivatives of this compound were also obtained as potential agents for photodynamic therapy of cancers \[[@CR17]\]. Glycosidic porphyrins obtained from the butyric acid derivative of tritolylphenylporphyrin were also designed as potential PDT agents \[[@CR18]\].Fig. 2Synthesized compounds

Results and discussion {#Sec2}
======================

To the best of our knowledge no derivatives with carboxyl groups at the distal ends of alkyl chains have been investigated for their usefulness in PDT. We thus decided to investigate compounds with alkyl chains of different lengths separating the porphyrin fragment from the carboxyl group. To synthesize alkyl precursors with *n* = 4, 5, 6, 7, and 11 we used the classic method of obtaining carboxyl derivatives starting from suitable dibromoalkyl derivatives and malonic acid diethyl ester \[[@CR19], [@CR20]\]. The yields of the obtained diethyl (bromoalkyl)malonates were not very high but this could be expected, especially for shorter alkyl chains. These compounds quite easily undergo intramolecular cyclization reaction under the reaction conditions \[[@CR21], [@CR22]\]. Hydroxyphenyltritolylporphyrin (**3**) was obtained according to Ref. \[[@CR23]\]. Diethyl (ω-bromoalkyl)malonates were coupled to a hydroxyl fragment of porphyrin using NaOH in DMF (Scheme [1](#Sch1){ref-type="fig"}). Under the reaction conditions the monocarboxy derivatives were obtained directly; in the presence of NaOH hydrolysis of the ester took place, whereas DMF distillation at an elevated temperature led to simultaneous decarboxylation of the malonic acid derivative. Exceptional for this synthetic route were the reactions of diethyl (3-bromopropyl)malonate leading to a malonic acid derivative and of diethyl (4-bromobutyl)malonate which gave a pentyloxy derivative of tetraphenylporphyrin. The properties of the obtained derivative were compared with those of the similar compound obtained by direct alkylation of the hydroxyphenyl derivative of porphyrin with 1-bromopentane.Scheme 1 

Porphyrins **4** and **5** were obtained by a different method, direct reaction of a suitable ethyl ester of ω-bromoalkyl acid with hydroxyl derivative of porphyrin (Scheme [2](#Sch2){ref-type="fig"}). The esters were hydrolysed to the corresponding carboxylic derivatives.Scheme 2 

All of the obtained porphyrins **4**--**8** had characteristic common bands in the visible part of the UV--visible spectrum. They have very strong absorption peaks centred at 422 nm (Soret band) and four other peaks centred at 519, 555, 594, and 650 nm (Q bands). The spectra clearly identify the porphyrinic chromophores of compounds **4**--**8**. The minor differences between the absorption maxima of the porphyrins implied their photosensitizing properties are also comparable. UV--visible data for all the compounds are listed in Table [1](#Tab1){ref-type="table"}.Table 1UV--visible spectra of compounds **4**--**9**, **11**, and **12** \[*λ*(log *ε*)\] in dichloromethane solutionDerivativeSoret/nmQ~IV~/nmQ~III~/nmQ~II~/nmQ~I~/nm**4**422 (5.38)517 (3.95)554 (3.77)592 (3.51)650 (3.63)**5**422 (5.54)518 (4.04)555 (3.84)592 (3.57)651 (3.58)**6**422 (5.57)519 (4.10)555 (3.86)594 (3.60)650 (3.58)**7**422 (5.58)519 (4.17)555 (3.94)594 (3.67)650 (3.66)**8**422 (5.57)519 (4.13)555 (3.90)594 (3.63)650 (3.67)**9**422 (5.70)519 (4.30)554 (4.07)593 (3.81)649 (3.77)**11**422 (5.46)518 (4.05)555 (4.05)594 (3.55)650 (3.52)**12**422 (5.11)517 (3.67)554 (3.47)594 (3.21)651 (3.31)

Fluorescence spectra of all porphyrins and TPP as a reference are similar in shape, and consist of two bands at 654 and 720 nm. From Table [2](#Tab2){ref-type="table"} we can see that the quantum yields of all the porphyrins are almost identical with that of the reference (TPP). The photostability of compounds **4**--**9**, **11**, and **12** was determined for their chloroform solutions at 25 °C. The results presented in Table [3](#Tab3){ref-type="table"} show good photostability of the compounds which indicates their potential usefulness for PDT.Table 2Fluorescence emission maxima, wavelengths (*λ* ~max~), and fluorescence quantum yields (Φ~F~) for compounds **4**--**9** and **11** and tetraphenylporphyrin (TPP) as reference; log *P* ~Rekker~ and log *P* ~exp~ for compounds **5**--**9** and **11**Photosensitizer*λ* ~max~1/nm*λ* ~max~2/nmΦ~F~log *P* ~Rekker~log *P* ~exp~**4**6537200.11----**5**6527180.119.088.25**6**6547190.139.6010.79**7**6547210.1110.1212.05**8**6547200.1112.1918.48**9**6547200.119.398.85**11**6547200.119.558.92**TPP**6527180.1----Table 3Photostability of compounds **4**--**9**, **11**, and **12**Photosensitizer0153045607590**4**100999998979795**5**100999696959595**6**1001009999979696**7**1001009998989797**8**100999899969595**9**100989897969696**11**100999998979795**12**1001009897969696For irradiation, visible light from two 36-W fluorescent lamps was used and the light intensity was adjusted to 16.5 W/m^2^. Photostability was determined by monitoring the intensity of the Soret band after a defined irradiation time (0--90 min)

Mass spectrometric analysis of all the synthesized porphyrins was performed by use of the ESI--MS technique. The mass spectra (positive mode) of all the porphyrins contained a base peak corresponding to the intact porphyrin---no fragment ions were detected. For porphyrins **6**--**8** and **10** the most intense ions appeared when sodium cations were present in the solutions.

Lipophilicity is an important molecular descriptor very often correlated with the biological activity of drugs and other compounds. It is characterized, for example, by the logarithm of a partition coefficient (log *P*). We determined log *P* values of all the compounds by a TLC method. Table [2](#Tab2){ref-type="table"} shows values calculated by use of the $\documentclass[12pt]{minimal}
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Solubility in polar solvents is a serious obstacle for the synthesized compounds. As could be expected, elongation of the alkyl chain led to increased hydrophobicity of the whole molecule. As a result, this often leads to aggregation and precipitation of porphyrins from solutions used for biological investigations. Currently, all these compounds are undergoing biological investigation using liposomal formulations which can substantially reduce the extent of photosensitizer aggregation and can be valuable carriers and delivery systems.

Conclusions {#Sec3}
===========

Novel mono-carboxyalkyloxyphenyl derivatives of porphyrin were synthesized and their physicochemical properties were examined. Quantum yields of all the obtained porphyrins are almost identical with that of the reference compound (TPP). Information about the lipophilicity of the examined compounds can prove helpful in further research on their potential medical uses. Their balanced hydrophobic--hydrophilic properties make it possible to place them in systems (e.g. micelles, liposomes) similar to natural biological membranes.

Experimental {#Sec4}
============

All chemical reagents were purchased from Aldrich or Acros and were used without further purification. ^1^H NMR and ^13^C NMR spectra were recorded in CDCl~3~ using a Varian spectrometer (400 MHz) with TMS as reference. UV--visible spectra were recorded in dichloromethane solutions using a Genesys 6 (ThermoSpectronic) spectrophotometer. Fluorescence spectra of the samples were recorded on a Varian Eclipse Cary-fluorescence spectrophotometer. ESI MS spectra were acquired using an LCQ DUO Finnigan Thermoquest or a Varian MS-500 instrument. Porphyrin solutions were directly injected into the ion source by use of a syringe pump.

General procedure for diethyl (ω-bromoalkyl)malonates {#Sec5}
-----------------------------------------------------

Diethyl malonate (0.05 mol), 1,ω-dibromoalkane (0.05 mol), 0.375 g tetrabutylammonium iodide (1 mmol), and 15 cm^3^ toluene were placed in a flask. A solution of 17.25 g K~2~CO~3~ in 15 cm^3^ water was added. The obtained mixture was stirred and heated to reflux for 20 h. After cooling to room temperature the solid was removed by suction. The organic phase was separated and the aqueous phase was extracted with toluene (3 × 10 cm^3^). The combined organic layers were washed with water and dried over anhydrous magnesium sulfate. After evaporating the solvent the product was distilled under reduced pressure.

### *Diethyl (3*-*bromopropyl)malonate* {#d30e1391}

Yield 16%; b.p.: 140--145 °C (7--8 mbar), lit. 135 °C (4 mbar) \[[@CR28]\], 121--123 °C (2 mbar) \[[@CR19]\].

### *Diethyl (4*-*bromobutyl)malonate* {#d30e1406}

Yield 16%; b.p.: 104--106 °C (3--4 mbar), lit. 133--136 °C (2 mbar) \[[@CR29]\].

### *Diethyl (5*-*bromopentyl)malonate* {#d30e1418}

Yield 21%; b.p.: 178--180 °C (8 mbar), lit. 153 °C (3 mbar) \[[@CR30]\]; 159--161 °C (3 mbar) \[[@CR31]\].

### *Diethyl (6*-*bromohexyl)malonate* {#d30e1433}

Yield 17%; b.p.: 175--178 °C (9 mbar), lit. 185--187°°C (10 mbar) \[[@CR32]\]; 193 °C (12 mbar) \[[@CR31]\].

### *Diethyl (10*-*bromodecyl)malonate* {#d30e1448}

Yield 20%; b.p.: 222--224 °C (7--8 mbar), lit. 123 °C (0.02 mbar) \[[@CR20], [@CR33]\].

General procedure for 5-\[4-(carboxyalkyloxy)phenyl\]-10,15,20-tritolylporphyrins {#Sec6}
---------------------------------------------------------------------------------

5-(4-Hydroxyphenyl)-10,15,20-tritolylporphyrin (0.24 mmol), solid NaOH (0.8 mmol), and 20 cm^3^ DMF were placed in a round-bottomed flask. The mixture was stirred at room temperature until NaOH was dissolved. Then 2 mmol diethyl (ω-bromoalkyl)malonate were added and the resulting mixture was stirred at room temperature for 24 h. After evaporation of the DMF under reduced pressure 50 cm^3^ dichloromethane was added to the residue. The resulting solution was washed with water (5 × 50 cm^3^) and dried over MgSO~4~. After evaporation of the solvent the crude product was washed with petroleum ether (20 cm^3^) and chromatographed on silica with dichloromethane.

### *5*-*\[4*-*(5*-*Carboxypentyloxy)phenyl\]*-*10,15,20*-*tritolylporphyrin* (**5**, C~53~H~46~N~4~O~3~) {#d30e1483}

Yield 14%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.86 (m, 8H), 8.10 (d, 2H, *J* = 8.4 Hz), 8.09 (d, 6H, *J* = 8.0 Hz), 7.54 (d, 6H, *J* = 8.0 Hz), 7.25 (d, 2H, *J* = 8.4 Hz), 4.24 (t, 2H), 2.70 (s, 9H), 2.51 (t, 2H), 2.01 (q, 2H), 1.86 (q, 2H), 1.72 (q, 2H), −2.76 (bs, 2H) ppm; ESI--MS: *m*/*z* = 787 (100) \[M + H\]^+^.

### *5*-*\[4*-*(6*-*Carboxyhexyloxy)phenyl\]*-*10,15,20*-*tritolylporphyrin* (**6**, C~54~H~48~N~4~O~3~) {#d30e1552}

Yield 57%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.86 (m, 8H), 8.11 (d, 2H, *J* = 8.4 Hz), 8.10 (d, 6H, *J* = 8.0 Hz), 7.55 (d, 6H, *J* = 8.0 Hz), 7.27 (d, 2H, *J* = 8.4 Hz), 4.27 (t, 2H), 3.55 (t, 2H), 2.71 (s, 9H), 2.10--2.00 (m, 4H), 1.77 (q, 2H), 1.53 (q, 2H), --2.76 (bs, 2H) ppm; ESI--MS: *m*/*z* = 823 (100) \[M + Na\]^+^.

### *5*-*\[4*-*(7*-*Carboxyheptyloxy)phenyl\]*-*10,15,20*-*tritolylporphyrin* (**7**, C~55~H~50~N~4~O~3~) {#d30e1621}

Yield 14%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.85 (m, 8H), 8.10 (d, 2H, *J* = 8.4 Hz), 8.09 (d, 6H, *J* = 8.0 Hz), 7.54 (d, 6H, *J* = 8.0 Hz), 7.27 (d, 2H, *J* = 8.4 Hz), 4.24 (t, 2H), 3.50 (t, 2H), 2.70 (s, 9H), 1.99 (q, 4H), 1.66 (q, 4H), 1.52 (m, 2H), −2.76 (bs, 2H) ppm; ESI--MS: *m*/*z* = 837 (100) \[M + Na\]^+^.

### *5*-*\[4*-*(11*-*Carboxyundecyloxy)phenyl\]*-*10,15,20*-*tritolylporphyrin* (**8**, C~59~H~58~N~4~O~3~) {#d30e1690}

Yield 18%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.85 (m, 8H), 8.10 (d, 2H, *J* = 8.4 Hz), 8.09 (d, 6H, *J* = 8.0 Hz), 7.55 (d, 6H, *J* = 8.0 Hz), 7.27 (d, 2H, *J* = 8.4 Hz), 4.25 (t, 2H), 3.43 (t, 2H), 2.70 (s, 9H), 2.00 (q, 2H), 1.90 (q, 2H), 1.62 (q, 2H), 1.53--1.20 (m, 12H), −2.76 (bs, 2H) ppm; ESI--MS: *m*/*z* = 894 (100) \[M + Na\]^+^.

### *5*-*\[4*-*\[4,4*-*Bis(ethoxycarbonyl)butyloxy\]phenyl\]*-*10,15,20*-*tritolylporphyrin* (**9**, C~57~H~52~N~4~O~5~) {#d30e1759}

Yield 27%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.84 (m, 8H), 8.10 (d, 2H, *J* = 8.4 Hz), 8.09 (d, 6H, *J* = 7.6 Hz), 7.54 (d, 6H, *J* = 7.6 Hz), 7.24 (d, 2H, *J* = 8.4 Hz), 4.27 (q, 4H), 3.56 (t, 1H), 2.69 (s, 9H), 2.27 (q, 2H), 2.04 (q, 2H), 1.51 (bs, 2H), 1.33 (t, 6H), −2.76 (bs, 2H) ppm; ESI--MS: *m*/*z* = 873 (100) \[M + H\]^+^.

### *5*-*(4*-*Pentyloxyphenyl)*-*10,15,20*-*tritolylporphyrin* (**10**, C~52~H~46~N~4~O) {#d30e1828}

Yield 14%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.87 (m, 8H), 8.11 (d, 2H, *J* = 8.4 Hz), 8.10 (d, 6H, *J* = 8.0 Hz), 7.55 (d, 6H, *J* = 8.0 Hz), 7.27 (d, 2H, *J* = 8.4 Hz), 4.23 (t, 2H), 2.71 (s, 9H), 1.99 (q, 2H), 1.62 (q, 2H), 1.53 (q, 2H), 1.05 (t, 3H), −2.73 (bs, 2H) ppm; ESI--MS: *m*/*z* = 765 (100) \[M + Na\]^+^, 743 (100) \[M + H\]^+^; UV--Vis (CH~2~Cl~2~): *λ*~max~ (log *ε*) = 422 (5.54), 519 (4.13), 555 (3.89), 593 (3.63), 650 (3.60) nm.

General procedure for 5-\[4-\[ω-(ethoxycarbonyl)alkyloxy\]phenyl\]-10,15,20-tritolylporphyrins {#Sec7}
----------------------------------------------------------------------------------------------

5-(4-Hydroxyphenyl)-10,15,20-tritolylporphyrin (100 mg, 0.15 mmol), 5 mg NaH (0.2 mmol), and 50 cm^3^ DMF were placed in a round-bottomed flask and stirred at room temperature for 30 min. Then 1 mmol ethyl ω-bromoalkylcarboxylate was added and the resulting mixture was stirred at 80 °C for 48 h. After evaporation of the DMF under reduced pressure 50 cm^3^ dichloromethane was added to the residue. The resulting solution was washed with water (3 × 50 cm^3^) and dried over MgSO~4~. After evaporation of the solvent the crude product was washed with petroleum ether (20 cm^3^) and chromatographed on silica with dichloromethane--ethanol 30:1 (*v*/*v*).

### *5*-*\[4*-*\[4*-*(Ethoxycarbonyl)butyloxy\]phenyl\]*-*10,15,20*-*tritolylporphyrin* (**11**, C~54~H~48~N~4~O~3~) {#d30e1936}

Yield 33%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.85 (m, 8H), 8.11 (d, 2H, *J* = 8.0 Hz), 8.09 (d, 6H, *J* = 7.6 Hz), 7.55 (d, 6H, *J* = 7.6 Hz), 7.27 (d, 2H, *J* = 8.0 Hz), 4.28 (t, 2H), 4.21 (q, 2H), 2.71 (s, 9H), 2.52 (q, 2H), 2.03 (m, 4H), 1.33 (t, 3H), −2.76 (bs, 2H) ppm; ^13^C NMR (125 MHz, CDCl~3~): *δ* = 173.19, 155.75, 139.33, 137.32, 135.68, 134.57, 134.53, 130.89, 127.42, 120.09, 120.05, 113.67, 60.44, 33.36, 33.03, 32.04, 23.55, 21.53, 14.26 ppm; ESI--MS: *m*/*z* = 801 (100) \[M + H\]^+^.

### *5*-*\[4*-*\[5*-*(Ethoxycarbonyl)pentyloxy\]phenyl\]*-*10,15,20*-*tritolylporphyrin* (**12**, C~55~H~50~N~4~O~3~) {#d30e2015}

Yield 29%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.85 (m, 8H), 8.11 (d, 2H, *J* = 8.0 Hz), 8.10 (d, 6H, *J* = 7.6 Hz), 7.55 (d, 6H, *J* = 7.6 Hz), 7.27 (d, 2H, *J* = 8.0 Hz), 4.26 (t, 2H), 4.19 (q, 2H), 2.71 (s, 9H), 2.44 (t, 2H), 2.01 (q, 2H), 1.84 (q, 2H), 1.69 (q, 2H), 1.31 (t, 3H), −2.76 (bs, 2H) ppm; ^13^C NMR (125 MHz, CDCl~3~): *δ* = 173.75, 158.89, 139.36, 137.32, 135.61, 134.54, 129.60, 129.07, 127.43, 120.10, 112.72, 67.98, 60.35, 34.40, 29.23, 25.90, 24.90, 21.55, 14.35 ppm; ESI--MS: *m*/*z* = 815 (100) \[M + H\]^+^.

General procedure for 5-(4-carboxyalkyloxyphenyl)-10,15,20-tritolylporphyrins from ethyl ester {#Sec8}
----------------------------------------------------------------------------------------------

5-\[4-(ω-Ethoxycarbonylalkyloxy)phenyl\]-10,15,20-tritolylporphyrin (0.03 g, \~0.04 mmol) dissolved in 10 cm^3^ dichloromethane was added to a solution of sodium ethoxide (1 g sodium dissolved in 10 cm^3^ ethanol). One drop of water was added to the mixture. The reaction mixture was stirred for 3 h at room temperature. The solution was then acidified to pH 7 with 1 [M]{.smallcaps} HCl, washed with water (3 × 30 cm^3^), dried over Na~2~SO~4~, and concentrated. Purification by column chromatography on silica gel (elution with CH~2~Cl~2~--EtOH, 25:1 (*v*/*v*) afforded the product.

### *5*-*\[4*-*(4*-*Carboxybutyloxy)phenyl\]*-*10,15,20*-*tritolylporphyrin* (**4**, C~52~H~44~N~4~O~3~) {#d30e2130}

Yield 24%; ^1^H NMR (400 MHz, CDCl~3~): *δ* = 8.85 (d, 8H), 8.09 (d, 8H, *J* = 8.0 Hz), 7.54 (d, 6H, *J* = 8.0 Hz), 7.24 (d, 2H, *J* = 8.0 Hz), 4.26 (t, 2H), 2.76 (s, 9H), 2.59 (q, 2H), 2.03 (q, 2H), 1.62 (m, 2H), −2.76 (bs, 2H) ppm; ESI--MS: *m*/*z* = 773 (100) \[M + H\]^+^.

*5*-*\[4*-*(5*-*Carboxypentyloxy)phenyl\]*-*10,15,20*-*tritolylporphyrin* (**5**) was obtained by this method in 19% yield.
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